What is Lactulose For?
Lactulose is primarily indicated for treating and preventing hepatic encephalopathy (HE) in patients with cirrhosis, and secondarily for managing chronic constipation. 1
Primary Indication: Hepatic Encephalopathy
Lactulose is the first-line treatment for hepatic encephalopathy, a brain dysfunction resulting from liver impairment or portosystemic shunting. 2, 1
Mechanism of Action
Lactulose works through multiple mechanisms 1:
- Acidifies the colon by bacterial fermentation, trapping ammonia as ammonium ions (NH4+) and preventing absorption
- Promotes ammonia elimination through its laxative effect
- Alters gut microbiota, inhibiting ammoniagenic bacteria while promoting beneficial bacteria like Bifidobacterium
- Reduces blood ammonia levels by 25-50%, which correlates with improved mental status 1
Clinical Applications in HE
For acute overt HE (OHE): Lactulose is strongly recommended to improve patient outcomes and prevent recurrence (strong recommendation, moderate certainty). 2 Dosing is 10-20 g (15-30 mL) every 2 hours until 2 soft bowel movements occur, then reduce to 2-4 times daily. 2
For prevention of HE recurrence: After an initial OHE episode, lactulose titrated to 2-3 soft bowel movements daily is the recommended first-line outpatient therapy (strong recommendation, high certainty). 2 This has been shown to reduce readmissions and improve long-term outcomes.
For covert/minimal HE (MHE/CHE): Lactulose is suggested over no treatment, though evidence is less robust (conditional recommendation, low certainty). 2
Critical Dosing Considerations
Careful titration is essential to avoid complications. 2 Overuse can lead to:
- Dehydration and hypernatremia (particularly dangerous—associated with 60% mortality in one study) 3
- Perianal irritation
- Ileus and aspiration risk
- Hypokalemia
Rectal lactulose carries significant risk: It is the strongest independent predictor of hypernatremia (OR=7.12) and should be used cautiously. 3 Doses ≥485 g over 5 days are associated with increased hypernatremia risk.
Secondary Indication: Chronic Constipation
For chronic idiopathic constipation (CIC): Lactulose is suggested for patients who fail or are intolerant to over-the-counter therapies (conditional recommendation, very low certainty). 4
Dosing for Constipation
- FDA-approved dose: 10-20 g (15-30 mL or 1-2 packets) daily 4
- Titrate based on response and tolerability
Limitations for Constipation Use
- Bloating and flatulence are common, dose-dependent side effects that may limit use 4
- Evidence quality is lower than for HE
- Other osmotic laxatives (like magnesium oxide or polyethylene glycol) may be preferred first-line options for simple constipation
Additional Emerging Uses
While not primary indications, research suggests lactulose may have benefits in:
- Prebiotic effects at low doses: Enhances Bifidobacterium growth and short-chain fatty acid production 5, 6
- Mineral absorption: May improve calcium and magnesium absorption 5
- Bowel preparation: Shows promise for colonoscopy prep in inflammatory bowel disease patients 7
Key Clinical Pitfalls
- Hypernatremia risk: Monitor sodium levels closely, especially with high-dose or rectal administration 3
- Non-adherence is common: Large volumes, frequent dosing, unpleasant taste, and side effects contribute to poor adherence—patient education is critical 8
- Not for acute constipation: Lactulose is poorly absorbed and reaches the colon unchanged; effects take time 1
- Contraindicated in galactosemia: Contains <1.6 g galactose per 15 mL 1